Back
NewAmsterdam Pharma Co NV Vs. Pharming Group Industry Stock Comparison
Sell
46
NAMS
NewAmsterdam Pharma Co NV
Last Price:
$25.90
Seasonality Move:
37.93%
Buy
65
PHAR
Pharming Group
Last Price:
$9.95
Seasonality Move:
1.15%
Sell
46
NewAmsterdam Pharma Co NV (NAMS)
is a Sell
Is NewAmsterdam Pharma Co NV a Buy, Sell or Hold?
-
The current NewAmsterdam Pharma Co NV [NAMS] share price is $25.94. The Score for NAMS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NAMS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Pharming Group (PHAR)
is a Buy
Is Pharming Group a Buy, Sell or Hold?
-
The current Pharming Group [PHAR] share price is $9.89. The Score for PHAR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
PHAR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NAMS Stock Price Chart
What is NewAmsterdam Pharma Co NV's stock price today?
-
The NewAmsterdam Pharma Co NV share price today is $25.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAMS is experiencing slight buying pressure.
PHAR Stock Price Chart
What is Pharming Group's stock price today?
-
The Pharming Group share price today is $9.89The current trend is moderately bullish and PHAR is experiencing selling pressure, which indicates risk of future bearish movement.
NAMS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.2 | Buy |
Relative Strength Index (14 RSI): | 62.17 | Buy |
Chaikin Money Flow: | 112221 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.5 - 26.7) | Buy |
Bollinger Bands (100): | (15.98 - 23.22) | Buy |
PHAR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.55 | Buy |
Relative Strength Index (14 RSI): | 57.79 | Buy |
Chaikin Money Flow: | -4754 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.88 - 10.02) | Buy |
Bollinger Bands (100): | (7.47 - 9.07) | Buy |
NAMS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.86 | Buy |
20-day SMA: | 24.58 | Buy |
50-day SMA: | 22.37 | Buy |
200-day SMA: | 19.72 | Buy |
8-day EMA: | 25.74 | Buy |
20-day EMA: | 24.72 | Buy |
50-day EMA: | 22.69 | Buy |
200-day EMA: | 19.45 | Buy |
PHAR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.24 | Sell |
20-day SMA: | 9.3 | Buy |
50-day SMA: | 8.56 | Buy |
200-day SMA: | 8.72 | Buy |
8-day EMA: | 9.97 | Sell |
20-day EMA: | 9.43 | Buy |
50-day EMA: | 8.82 | Buy |
200-day EMA: | 8.98 | Buy |
NewAmsterdam Pharma Co NV Earnings Growth & NAMS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.08 per share.
Pharming Group Earnings Growth & PHAR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.03 per share.
NewAmsterdam Pharma Co NV Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pharming Group Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |